跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AR-24
首页
药物
AR-24
AR-24
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Indole-type derivatives as inhibitors of p38 kinase
US 7238712 B2
申请人: SCIOS INC
优先权: 2002
US
6 件公开
US 6867209 B1
申请人: SCIOS INC
优先权: 2000
US
Functionalized phenolic esters and amides and polymers therefrom
US 2006173065 A1
申请人: BEZWADA RAO S
优先权: 2005
US
4 件公开
Cycloalkyl-phenyl-substituted cyclic ketoenoles
EP 2186791 A1
申请人: BAYER CROPSCIENCE AG
优先权: 2007
EP
3 件公开
COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE
EP 3939970 A4
申请人: IDEMITSU KOSAN CO
优先权: 2019
CN
EP
2 件公开
Inhibitors of p38 kinase
US 2003092717 A1
申请人: DUGAR SUNDEEP
优先权: 2001
US
2 件公开
Organometallic monoacylalkylphosphines
US 6969733 B2
申请人: CIBA SC HOLDING AG
优先权: 2002
US
2 件公开
Antiandrogen oligonucleotides usable for the treatment of dermatological androgen-related disorders relating to androgen metabolism, their pharmaceutical compositions, their uses and treatment method
US 2006009429 A1
申请人: KERNER NESTOR A
优先权: 2003
US
2 件公开
Liquid-crystalline compound and organic semiconductor device containing the compound
US 8480926 B2
申请人: SASADA YASUYUKI
优先权: 2010
US
2 件公开
Indole-type inhibitors of p38 kinase
US 2003100588 A1
申请人: LUEDTKE GREGORY
优先权: 2001
US
Linked dihydrazone-based charge transport compounds
US 6899984 B2
申请人: SAMSUNG ELECTRONICS CO LTD
优先权: 2003
US
第 1 / 3 页
上一页
下一页
药物
反馈